Position in XERS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,841,464
-$237,586 QoQ
Shares Held
611,296
-2.0% QoQ
Ownership
0.335%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#38
of 236 holders
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $47,294,180 across 23 Drug Manufacturers - Specialty & Generic names. XERS ranks #4 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
165,410 | $11,886,362 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
106,112 | $8,783,951 | |
| 3 | BIOA |
BioAge Labs, Inc.
|
354,395 | $8,686,221 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
611,296 | $4,841,464 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
186,588 | $3,351,120 | |
| 6 | ETON |
Eton Pharmaceuticals, Inc.
|
86,249 | $3,122,213 | |
| 7 | EOLS |
Evolus, Inc.
|
253,817 | $1,761,489 | |
| 8 | AQST |
Aquestive Therapeutics, Inc.
|
282,568 | $1,175,482 |
All Filings in XERS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,841,464 | 611,296 | Shares | Sole | 2026-08-03 | |
| 2025-09-30 | $5,079,050 | 623,962 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,136,094 | 243,275 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,797,537 | 691,719 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $3,196,953 | 1,121,738 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $84,428 | 35,927 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $231,923 | 124,690 | Shares | Sole | 2023-11-21 | |
| No filing history on record for this holder in this stock. | ||||||